Randolph Stephenson, MD
Neurology · Fairfax, VANPI 1538352430
Payments from drug & device makers
Across 23 payments — averaging $21.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Acadia Pharmaceuticals Inc$81
- AbbVie$75
- Kyowa Kirin, Inc.$63
- Supernus Pharmaceuticals, Inc.$49
- GE HealthCare$38
- Amgen$35
- plus $143 from 7 others
What the payments were for
- Speaking & faculty fees$245%
- Food & beverage$45995%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Acadia Pharmaceuticals Inc | 4 | $81 |
| AbbVie(2 entities) | 4 | $75 |
| Kyowa Kirin, Inc. | 3 | $63 |
| Supernus Pharmaceuticals, Inc. | 2 | $49 |
| GE HealthCare | 1 | $38 |
| Amgen | 1 | $35 |
| Vertical Pharmaceuticals, LLC | 2 | $29 |
| Acorda Therapeutics, Inc | 1 | $24 |
| Neurocrine Biosciences, Inc. | 1 | $24 |
| Abbott | 1 | $21 |
| Adamas Pharmaceuticals, Inc. | 1 | $16 |
| Pfizer | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
How this compares
$484 in reported general payments places this provider in the 35th percentile of 474 neurology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GammakedImmune Globul G/Gly/Iga Avg 46 | 13 | $403,035 |
| RytaryCarbidopa/Levodopa | 209 | $349,780 |
| GocovriAmantadine Hcl | 22 | $100,839 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 791 | $27,059 |
| NeuproRotigotine | 12 | $20,863 |
| Rasagiline Mesylate | 70 | $14,544 |
| Entacapone | 44 | $8,579 |
| Carbidopa-Levodopa-EntacaponeCarbidopa/Levodopa/Entacapone | 16 | $7,593 |
| Rivastigmine | 11 | $3,943 |
| AmantadineAmantadine Hcl | 67 | $3,346 |
| Pramipexole DihydrochloridePramipexole Di-Hcl | 91 | $3,215 |
| Carbidopa | 20 | $3,039 |
| Gabapentin | 191 | $2,889 |
| Selegiline Hcl | 16 | $1,328 |
| Memantine Hcl | 35 | $1,113 |
Paid to pharmacies, not to this prescriber.
Other neurology in Fairfax
- Rahul DaveFairfax$1M
- John RothrockFairfax$504K
- James SimsarianFairfax$173K
- Laura CinskiFairfax$124K
- Abigail LawlerFairfax$107K
- Michelle BetzVirginia Beach$3.3M
- Daniel CohenNorfolk$2.9M
- Heidi CraytonVienna$2.5M
- Ramsey FalconerAlexandria$2.4M
- Robert ShinCharlottesville$2.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.